ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981

White House Agrees To Pay Raise For NCI, NIH, NHLI Chiefs

February 27, 1976

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

ACS Clinical Awards Available For 1996

March 31, 1995

NCI CTEP Approved Trials For the Month of December

December 27, 2013